Editor's Picks Analysis & Opinion

A couple of weeks ago, we advocated investors to stop any build-up in PGM positions as the platinum metals group appeared to still lack the right signals for a buy, despite posting their first...

It really requires nerves of steel to be an investor in Tesla (NASDAQ:TSLA). Thanks to Elon Musk, its unpredictable and casual CEO, the company is always in the grip of speculation and uncertainty.The...

In September of this year, rumours began swirling that the SEC planned to approve the U.S.’ first Bitcoin ETF for trading. Speculation (and the price of Bitcoin) skyrocketed through early...

The latest data from the Bureau of Labor Statistics in the U.S. showed that gasoline prices increased by 6.1% from September to October and are up by nearly 50% year-to-date. The Biden administration...

The widowmaker trade—the ominous natural gas play that has been fatal to the careers of many who bet large and incorrectly on the price spread between winter and spring—is sharply down...

Many investors who have made fortunes via the market rarely sell once they’ve bought a cash-producing asset. This investing style is also very useful if your goal is to build a solid cash stream...

When Merck & Company (NYSE:MRK) introduced its COVID-19 pill Molnupiravir in mid October, shares of the New Jersey-based drugmaker immediately found momentum. The treatment has been shown to cut...

CVS Health Corp's (NYSE:CVS) Q3 EPS, reported on Nov. 3, beat consensus expectations by almost 11%. Since closing at the YTD high of $96.34 on that day, the shares have fallen slightly.CVS has...